ELV: Flat Base detected on 21 Apr 2026

ELV is forming a flat base pattern with strong technical support. The stock sits at $319.36, compressed between support at $273.18 and resistance at $324.61, yielding a 1.88% range width. Pattern quality metrics are robust: structure score of 13.0, breakout score of 13.0, and volume score of 12.0 reflect well-defined consolidation. The overall score of 78 with 70.55% win probability signals a credible setup. RSI at 59.48 shows neutral momentum—neither overbought nor oversold—while MACD histogram at 2.3957 is positive. A breakout above $324.61 would target $333.20 conservatively, representing a 3.4% move from current price.

Elevance Health will release first quarter 2026 financial results on April 22, 2026, at 6:00 a.m. Eastern Daylight Time, meaning earnings drop tomorrow—creating a critical catalyst risk. Analysts forecast ELV to post a profit of $10.61 per share, down 11.4% from the year-ago quarter, with the market expecting revenue to be flat year on year. However, Elevance Health is up 11% during the last month, suggesting recent accumulation. A significant tailwind emerged on April 6, 2026 when CMS confirmed Medicare Advantage and Part D plans will receive a 2.48% average rate increase for 2027, which lifted sentiment despite near-term earnings pressure. Elevance's core Medicaid and Medicare businesses have faced ongoing pressures with lower risk-based membership and margin misalignment; the company's ability to improve margins and leverage care coordination to address cost trends will be closely watched.

A successful breakout above $324.61 resistance would validate continuation toward the $333.20 target, requiring volume confirmation at or above the 20-day average of 1.52M shares. The 70.55% win probability suggests historical edge, though the pattern remains vulnerable below support at $273.18—the invalidation level where this setup fails structurally. Given the flat base formation and multiple prior bullish patterns detected (ascending triangle from Feb 27, bull flag from March 9), momentum confluence supports upside, assuming earnings don't trigger a sharp reversal. The measured move indicates a contained 3-4% upside within the technical pattern window.

Q1 2026 earnings report drops April 22, 2026—a major volatility event occurring during the pattern maturation window. The company experienced a softer quarter with significant miss of full-year EPS guidance and lost 137,000 customers, ending with 45.23 million. EPS is likely down 11.4% and Health Benefits operating income is projected to plunge 13.7% year over year. Truist lowered ELV price target to $375 from $390 on April 13, indicating analyst retreat. The healthcare sector itself is in bearish regime (score 0.18), which contrasts with the stock's bullish market regime (0.94). Beta of 1.09 means above-average sensitivity to market swings. The 25.52% discount to 52-week highs reflects lingering damage from prior weakness, and the three-month performance of -14.29% suggests bears retain leverage.